Guía para la elaboración de fórmulas infantiles en polvo en el medio hospitalario. Sistema de análisis de peligros y puntos de control crítico

Vargas-Leguás, Hernán; Garrido, Virginia Rodríguez; Cuenca, Robayo; Pérez-Portabella, C.; Ferreiro, Susana; Campins-Martí, Magda

doi:10.1016/j.anpedi.2009.01.006

Cited by 7 publications

(8 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…La evaluación de los SFI en los dos hospitales con la guía adaptada "Sistema de análisis de peligros y puntos de control crítico" 19 , tuvo como resultado la identificación de diferentes falencias durante el proceso de reconstitución de FIP para obtener un producto inocuo (Tabla 1).…”

Section: Resultsunclassified

See 1 more Smart Citation

Contaminación microbiólogica en fórmulas infantiles en polvo en dos hospitales de Honduras

et al. 2019

View full text Add to dashboard Cite

Section: Resultsunclassified

“…Flujo de proceso del método aséptico utilizado para recoger muestras de FIP, adaptado de Vargas et al (2008)19 . Resultados de la evaluación del Servicio de Fórmulas Infantiles de los Hospitales I y II.…”

unclassified

Contaminación microbiólogica en fórmulas infantiles en polvo en dos hospitales de Honduras

et al. 2019

View full text Add to dashboard Cite

“…La lactancia materna es la forma más segura de alimentación para los lactantes: aporta la totalidad de los nutrientes necesarios para la primera etapa de la vida, protege contra las infecciones y tiene múltiples benefi cios para la salud y desarrollo integral en los niños (24). La Organización Mundial de la Salud recomienda su consumo exclusivo hasta los 6 meses de vida y en combinación con otros alimentos, hasta los 2 años (25).…”

Section: Discussionunclassified

Riesgo de contaminación por Cronobacter Sakazakii en leches en polvo para la nutrición de lactantes

et al. 2015

View full text Add to dashboard Cite

INTRODUCCIÓN En Chile, en el comercio existen actualmente 2 tipos de fórmulas infantiles para la nutrición infantil: líquidas listas para el uso, con un buen nivel de inocuidad, pero de menor consumo; y en polvo (LP), que son las más utilizadas a nivel mundial pero no estériles (1). Garantizar su inocuidad microbiológica es de gran preocupación para los organismos reguladores y productores, ya que están destinados a recién nacidos y niños que tienen un sistema inmunológico aún poco desarrollado y una microbiota intestinal poco

show abstract

“…There are different processes to elaborate infant formula; some are based on mixing powder components in hygienic conditions and others on reconstituting powder ingredients, applying heat treatment and spray drying (Watson 2022 ). In any case, powder formulas are not a sterile product, and inadequate conditions of production, storage and handling can be a risk to infant health (Vargas-Leguás et al 2009 ). For this reason, powdered milk products must be stored in a dry place, at temperatures below 20 °C and with a maximum relative humidity of 70%.…”

Section: Introductionmentioning

confidence: 99%

“…For this reason, powdered milk products must be stored in a dry place, at temperatures below 20 °C and with a maximum relative humidity of 70%. In addition, it is recommended for powder milk to be consumed within a maximum period of one month once the container is opened, and to be administered immediately once reconstituted or keep in refrigeration no more than 24 h (Vargas-Leguás et al 2009 ).…”

Section: Introductionmentioning

confidence: 99%

Effect of in vitro gastrointestinal digestion on the antibacterial activity of bioactive dairy formulas supplemented with lactoferrin against Cronobacter sakazakii

et al. 2022

View full text Add to dashboard Cite

Milk is a source of proteins with high nutritional value and relevant biological activities. Bioactive milk proteins, like lactoferrin, are important for newborn development and can also be used as ingredients in functional products to improve health. Lactoferrin is essential in infant’s diet, since protects against infections and promotes immune system maturation. Bovine lactoferrin is used to supplement formula milk in order to strengthen baby’s defences against some pathogenic bacteria. Thus, lactoferrin supplemented formula can be a barrier against emergent pathogens, such as Cronobacter sakazakii, which has caused great concern in the last few years. Milk proteins generate bioactive peptides in the digestion process, and it is known that industrial processing can modify their susceptibility to digestion. Treatments such as heating have been shown to denature whey proteins and make them more easily digestible. Therefore, the aim of this study was to analyze the effect of technological treatments and gastrointestinal digestion on the antibacterial activity against C. sakazakii of proteins present in dairy formulas supplemented with lactoferrin. Commercial bovine lactoferrin has been shown to have antibacterial activity against C. sakazakii, both in the native state and after static in vitro gastrointestinal digestion. In addition, the digests obtained from dairy formulas subjected to technological treatments, either homogenization or pasteurization, have higher antibacterial activity than non-treated formulas. The release of low molecular weight peptides during the in vitro gastric digestion is probably the cause that would explain the enhanced antibacterial activity of the digested dairy formulas.

show abstract

Guía para la elaboración de fórmulas infantiles en polvo en el medio hospitalario. Sistema de análisis de peligros y puntos de control crítico

Cited by 7 publications

References 2 publications

Contaminación microbiólogica en fórmulas infantiles en polvo en dos hospitales de Honduras

Contaminación microbiólogica en fórmulas infantiles en polvo en dos hospitales de Honduras

Riesgo de contaminación por Cronobacter Sakazakii en leches en polvo para la nutrición de lactantes

Effect of in vitro gastrointestinal digestion on the antibacterial activity of bioactive dairy formulas supplemented with lactoferrin against Cronobacter sakazakii

Contact Info

Product

Resources

About